SCHEMBL25745814

SCHEMBL25745814

CC(C)(C)c1ccc(Oc2cc(Oc3ccc(C(C)(C)C)cc3)c(Br)c(N)c2Br)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.55
▸ MAPT P10636 3/20 0.55
▸ NPC1 O15118 2/20 0.55
▸ ALDH1A1 P00352 2/20 0.55
▸ HPGD P15428 2/20 0.55
▸ MAPK1 P28482 1/20 0.55
▸ KDM4E B2RXH2 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ FGFR2 P21802 3/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ BCHE P06276 4/20 0.39
▸ ACHE P22303 4/20 0.39
▸ ICAM1 P05362 1/20 0.39
▸ SELE P16581 1/20 0.39
▸ MAOA P21397 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.37
▸ LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21480279 0.82 ALDH1A1 (0.48) RAB9AMAPTNPC1ALDH1A1HPGD
SCHEMBL25586333 0.77 MAPT (0.43) RAB9AMAPTNPC1ALDH1A1HPGD
SCHEMBL26256982 0.77 MAPT (0.50) RAB9AMAPTNPC1ALDH1A1HPGD
SCHEMBL25745816 0.76 ALDH1A1 (0.53) RAB9AMAPTNPC1ALDH1A1HPGD
SCHEMBL23638971 0.74 ALDH1A1 (0.47) RAB9AMAPTNPC1ALDH1A1HPGD
SCHEMBL23633176 0.72 ALDH1A1 (0.46) RAB9AMAPTNPC1ALDH1A1HPGD
SCHEMBL127279 0.72 RAB9A (0.77) RAB9AMAPTNPC1ALDH1A1HPGD
SCHEMBL427816 0.72 RAB9A (0.77) RAB9AMAPTNPC1ALDH1A1HPGD
SCHEMBL18118972 0.72 RAB9A (0.77) RAB9AMAPTNPC1ALDH1A1HPGD
SCHEMBL554687 0.71 ALDH1A1 (1.00) RAB9AMAPTNPC1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230200206-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-22 — — US disclosed
US-20230200206-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230200206-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME MCM4, MCM2, CCNL2 RAB9A 2357/4885MAPT 2879/4885NPC1 1738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback